Citius Pharmaceuticals, Inc. (CTXR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Citius Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.37x | -3.71x | -5.12x | -8.76x | -15.89x | -3.87x |
| P/B Ratio | 0.20x | 2.07x | 1.84x | 2.87x | 2.78x | 2.02x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.62x | 0.40x | 5.95x | 9.84x | 18.28x | 3.41x |
| Quick Ratio | 0.13x | 0.17x | 5.95x | 9.84x | 18.28x | 3.41x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.00x | 0.01x | 0.01x | 0.01x | 0.04x |
YoY = year-over-year change. Source: FMP..